ici 164384 has been researched along with triiodothyronine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albaladejo, V; Andre, J; Joly-Pharaboz, MO; Nicolas, B; Zhou-Li, F | 1 |
Bracke, ME; Mareel, MM; Van Larebeke, NA; Vyncke, BM | 1 |
Dinda, S; Moudgil, V; Sanchez, A | 1 |
3 other study(ies) available for ici 164384 and triiodothyronine
Article | Year |
---|---|
Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Topics: Breast Neoplasms; Cell Division; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor I; Pituitary Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Thyroid Hormone; RNA, Messenger; Tamoxifen; Transcription, Genetic; Triiodothyronine; Tumor Cells, Cultured | 1992 |
Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro.
Topics: Animals; Breast Neoplasms; Cell Aggregation; Cell Division; Cell Line; Cell Membrane; Chick Embryo; Dexamethasone; Estradiol; Estrogen Antagonists; Female; Humans; Myocardium; Neoplasm Invasiveness; Polyunsaturated Alkamides; Receptors, Cell Surface; Tretinoin; Triiodothyronine | 1991 |
Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Humans; Kinetics; Phosphorylation; Polyunsaturated Alkamides; Receptors, Estrogen; Retinoblastoma Protein; Triiodothyronine; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2002 |